Guinalac, Edna .

HRN: 13-02-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2024
AMPICILLIN 1GM (VIAL)
10/13/2024
10/19/2024
IV
2g
Q6
Prom X1h
Waiting Final Action 
10/14/2024
CEFUROXIME 500MG (TAB)
10/14/2024
10/20/2024
PO
1tab
BID
CS
Waiting Final Action 
10/14/2024
METRONIDAZOLE 500MG (TAB)
10/14/2024
10/20/2024
PO
1tab
TID
Cs
Waiting Final Action 
10/14/2024
CEFUROXIME 1.5GM (VIAL)
10/14/2024
10/15/2024
IV
1.5g
Q8
Cs
Waiting Final Action 
10/14/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/14/2024
10/15/2024
IV
500mg
Q8
Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: